Seeing Is Believing
Currently out of the existing stock ratings of Kristen Stewart, 57 are a BUY (58.76%), 14 are a SELL (14.43%), 26 are a HOLD (26.8%).
Analyst Kristen Stewart, carries an average stock price target met ratio of 79.45% that have a potential upside of 19.86% achieved within 370 days. Previously, Kristen Stewart worked at C. L. KING.
Kristen Stewart’s has documented 183 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TFX, Teleflex at 03-Nov-2024.
Analyst best performing recommendations are on AVNS (AVANOS MEDICAL).
The best stock recommendation documented was for AVNS (AVANOS MEDICAL) at 4/13/2020. The price target of $30 was fulfilled within 1 day with a profit of $1.62 (5.71%) receiving and performance score of 57.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$162
$33.46 (26.03%)
$159
6 days ago
(16-Oct-2025)
18/25 (72%)
$33.46 (26.03%)
499
Buy
$142
$13.46 (10.47%)
$144
7 days ago
(15-Oct-2025)
7/11 (63.64%)
$14.37 (11.26%)
317
Buy
$146
$17.46 (13.58%)
$141
7 days ago
(15-Oct-2025)
18/23 (78.26%)
$18.37 (14.39%)
376
Buy
$145
$16.46 (12.81%)
$137
3 months 5 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$145
$16.46 (12.81%)
$139
3 months 5 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
What Year was the first public recommendation made by Kristen Stewart?